UT School of Public Health San Antonio
San Antonio, Texas, 78229, United States
NCT Number: NCT06435338
The goal of this study is to learn if a patient decision tool for HPV vaccination works for decision-making among adults ages 27-45. Researchers will compare a web-based patient decision tool to an information sheet to see if the tool works for decision-making. Participants will take a baseline survey, view the intervention or control condition, and then take a follow-up survey.
Looking for future studies?
Notify Me27 year–45 year
All sexes
Interventional
Not applicable
San Antonio, Texas, 78229, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The patient decision aid for HPV vaccination among mid-adults, named HPV Decide. It is delivered online on a website.
Vaccine information sheet on HPV vaccination. Attention control condition.
Time frame: Immediate post-test
This scale has 16 items and 5 response categories. The decisional conflict scale (DCS) measures personal perceptions of: uncertainty in choosing options; modifiable factors contributing to uncertainty such as feeling uninformed, unclear about personal values and unsupported in decision making; and effective decision making (in full version) such as feeling the choice is informed, values-based, likely to be implemented and expressing satisfaction with the choice. The scores ranged from 0 "no conflict" to 100 "extreme decisional conflict."
Time frame: Immediate post-test
Decision conflict scale recommended for every day clinical practice. It has 4 items and two response categories. Scores range from 0 [extremely high decisional conflict] to 4 [no decisional conflict].
Time frame: Immediate post-test
16-item knowledge item related to human papillomavirus and human papillomavirus vaccination. Scale from 0 [low knowledge] to 16 [high knowledge].
Time frame: Immediate post-test
Intentions for information seeking, talking to a healthcare provider, and getting vaccinated
Time frame: Immediate post-test
Vaccine decision, including decide to get vaccinated, unsure, and decided not to get vaccinated
Time frame: Immediate post-test
Perceived expectation was assessed by asking participant agreement on a 5-point Likert scale to the following statement, "The effectiveness of the HPV vaccine will vary from person to person." Higher score indicates higher perceived effectiveness.
Time frame: Immediate post-test
Perceived risks of HPV infection were also assessed, including participants' perceptions of getting an HPV-associated infection genital/anal warts, or cancer in their lifetime. Response options ranged from very unlikely (lower score) to very likely (higher score).
How likely are you to get an HPV related cancer, like cervical, oral, or anal cancer, in your lifetime? How likely are you to get an HPV infection in your lifetime? How likely are you to get anal or genital warts in your lifetime?
Time frame: Immediate post-test
The Decision Self-Efficacy Scale evaluates an individual's self-confidence to make decisions on their own or with support from other sources. Scores range from 0 [extremely low self-efficacy] to 100 [extremely high self efficacy].
The University of Texas Health Science Center at San Antonio
Other
Acronym: HPV Decide
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07071415
Decision Aid, Geriatrics
New Haven, Connecticut, United States
View Trial DetailsNCT04466865
Behavior, Chronic Disease
Denver, Colorado, United States
View Trial DetailsNCT06625983
Colorectal Cancer Control and Prevention, Colorectal Cancer Screening
Boston, Massachusetts, United States
View Trial DetailsNCT06994832
Colonic Diseases, Colonic Neoplasms
Boston, Massachusetts, United States
View Trial Details